Inauguration symposium for the brand-new Theranostic Trial Centre (TTC) at Karolinska Universitetssjukhuset
This week, we attended the Inauguration symposium for the brand-new Theranostic Trial Centre (TTC) Karolinska Universitetssjukhuset in Stockholm, Sweden. We valued the opportunity to meet customers, partners and researchers in the field of theragnostics and discuss the latest developments.
The many fascinating lectures showcased that theragnostics and radioligand therapy are evolving rapidly and will bring more treatment options to patients. We were particularly excited about all the ongoing investigator-initiated trials, as the common goal of better care for patients can bring academia, healthcare, and industry together on the journey ahead.
We wish TTC the best of luck; we are excited to follow your journey and see what it might lead to for patients in the future.